ゲノム編集における変異検出キット市場：ゲノム別、用途別-2025-2030年世界予測

ゲノム編集における変異検出キット市場は、2023年に1億9,280万米ドルと評価され、2024年には2億2,274万米ドルに達すると予測され、CAGR 15.83%で成長し、2030年には5億3,951万米ドルに達すると予測されています。

ゲノム編集における変異検出キットは、ゲノム編集プロセスに起因するDNA配列の遺伝子変化を特定するために使用される不可欠なツールです。これらのキットは、医学研究、農業、バイオテクノロジーにおけるアプリケーションに不可欠であり、科学者はCRISPR、TALEN、ZFNなどのゲノム編集技術の効率と精度を評価することができます。これらのキットの必要性は、編集が成功したことを確認し、遺伝子組み換え生物や実験室で編集された細胞の安全性と有効性を保証する必要性から生じています。これらの用途は、医薬品開発のための医薬品、治療法開発のための臨床研究、改良作物品種の開発のための農業など、最終用途産業全体に広がっています。

変異検出キット市場は、ゲノム編集技術の採用拡大、バイオテクノロジー研究への投資増加、遺伝病治療の進歩などの要因によって牽引されています。主な成長要因としては、個別化医療に対する需要の拡大と、研究活動を後押しする遺伝性疾患の有病率の増加が挙げられます。潜在的なビジネスチャンスは、低リソース環境での広範な採用を促進できるコスト効率の高いハイスループット検出キットの開発にあります。企業は、精度の向上、コストの削減、キットの使用方法の簡素化などの技術革新を行うことで、こうした機会を活用することができます。

同市場における課題には、高度な検出キットの高コストや、市場拡大に影響を及ぼす可能性のある遺伝子組換え技術をめぐる規制上の課題などがあります。さらに、ゲノム編集に関する倫理的な懸念は、広く受け入れられる妨げとなる可能性があります。小さな変異を正確に検出することの複雑さなどの技術的課題は、市場の成長をさらに複雑にしています。

技術革新と研究が必要な分野には、携帯型検出装置の開発、検査プロセスの自動化、データ解析強化のためのバイオインフォマティクスツールとの統合などがあります。バイオテクノロジー企業と学術機関の共同研究は、さらなる進歩を促す可能性があります。市場は急速な技術開発と競争の激化を特徴としており、競争力を維持するためには継続的な技術革新と戦略的提携が必要となります。ゲノム編集結果の予測分析に人工知能のブレークスルーを活用することは、洞察を得て事業成長を達成するための有望な手段です。

市場力学：急速に進化するゲノム編集における変異検出キット市場の主要市場インサイトを公開

ゲノム編集における変異検出キット市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 遺伝性疾患とがんの有病率の増加
  • 遺伝子研究と個別化医療への投資の増加
• 市場抑制要因
  • ゲノム編集技術に関連する高コストと複雑な規制
• 市場機会
  • シーケンス技術とバイオインフォマティクスの革新
  • バイオテクノロジー企業と研究機関の共同研究の増加
• 市場の課題
  • 変異検出キットに関連する技術的限界と精度への懸念

ポーターのファイブフォース：ゲノム編集における変異検出キット市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ゲノム編集における変異検出キット市場における外部からの影響の把握

外部マクロ環境要因は、ゲノム編集における変異検出キット市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ゲノム編集における変異検出キット市場における競合情勢の把握

ゲノム編集における変異検出キット市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスゲノム編集における変異検出キット市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ゲノム編集における変異検出キット市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ゲノム編集における変異検出キット市場における成功への道筋を描く

ゲノム編集における変異検出キット市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患とがんの罹患率の増加
    • 遺伝子調査と個別化医療への投資増加
  • 抑制要因
    • ゲノム編集技術に伴う高コストと複雑な規制
  • 機会
    • シーケンシング技術とバイオインフォマティクスの革新
    • バイオテクノロジー企業と調査機関の連携強化
  • 課題
    • 変異検出キットに関連する技術的な制限と精度に関する懸念
• 市場セグメンテーション分析
  • ゲノム：幅広い応用と進行中の治療開発によりCRISPR/Cas9の商業化を拡大
  • 最終用途：学術調査機関による新たな遺伝子編集技術の開発に対する需要の増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ゲノム編集における変異検出キット市場ゲノム

• クリスパー/Cas9
• メガヌクレアーゼ
• TALEN/メガTAL
• ゼフ

第7章 ゲノム編集における変異検出キット市場：最終用途別

• 学術調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関

第8章 南北アメリカのゲノム編集における変異検出キット市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のゲノム編集における変異検出キット市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのゲノム編集における変異検出キット市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • イノクラスとウォッチメーカー・ゲノミクスが高度なゲノム編集ソリューションの開発に向けた戦略的提携を発表
  • FDA、プライムメディシンの初のプライム編集療法のINDを承認
  • リジェネロンとマンモス・バイオサイエンスが生体内CRISPR遺伝子編集の協力を開始
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Amoy Diagnostics Co., Ltd.
• Applied Biological Materials, Inc.
• Bio-Rad Laboratories
• BIOKE, B.V. by Cell Signaling Technology, Inc.
• Bioneer Corporation
• Biovision Inc. by Abcam Limited
• GenScript Biotech Corporation
• Illumina, Inc.
• Integrated DNA Technologies, Inc. by Danaher Corporation
• Launch Diagnostics Limited by Avacta Group Plc
• LGC Biosearch Technologies
• Lonza Group AG
• Medaysis Company
• Merck KGaA
• Mylab Discovery Solutions Pvt. Ltd.
• New England Biolabs
• New England Biolabs, Inc.
• Origene Technologies, Inc.
• Promega Corporation
• Qiagen N.V.
• Synthego Corporation
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.
• TransGen Biotech Co., Ltd.
• TRUPCR by Kilpest India Limited

LIST OF FIGURES

• FIGURE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET RESEARCH PROCESS
• FIGURE 2. MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MUTATION DETECTION KITS IN GENOME EDITING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MUTATION DETECTION KITS IN GENOME EDITING MARKET DYNAMICS
• TABLE 7. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY TALENS/MEGATALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 24. CANADA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 36. CHINA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 38. INDIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 73. ITALY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 81. POLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 83. QATAR MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY GENOME, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM MUTATION DETECTION KITS IN GENOME EDITING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. MUTATION DETECTION KITS IN GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. MUTATION DETECTION KITS IN GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2023

The Mutation Detection Kits In Genome Editing Market was valued at USD 192.80 million in 2023, expected to reach USD 222.74 million in 2024, and is projected to grow at a CAGR of 15.83%, to USD 539.51 million by 2030.

Mutation detection kits in genome editing are integral tools used to identify genetic alterations in DNA sequences resulting from genome editing processes. These kits are essential for applications in medical research, agriculture, and biotechnology, enabling scientists to assess the efficiency and precision of genome editing technologies such as CRISPR, TALENs, and ZFNs. The necessity of these kits stems from the need to confirm successful edits and ensure the safety and efficacy of genetically modified organisms or lab-edited cells. Their applications extend across end-use industries like pharmaceuticals for drug development, clinical research for therapeutic advancements, and agriculture for developing enhanced crop varieties.

The market for mutation detection kits is driven by factors such as the increasing adoption of genome editing technologies, rising investments in biotechnology research, and advancements in genetic disease therapies. A key growth influencer is the expanding demand for personalized medicine and the growing prevalence of genetic disorders, which drive research activities. Potential opportunities lie in developing cost-effective, high-throughput detection kits that can facilitate broader adoption in low-resource settings. Companies can capitalize on these opportunities by innovating to improve accuracy, reduce costs, and simplify kit usage.

Limitations in the market include the high cost of sophisticated detection kits and regulatory challenges surrounding genetic modification technologies that can impact market expansion. Additionally, ethical concerns regarding genome editing may hinder widespread acceptance. Technological challenges, such as the complexity of detecting small mutations accurately, further complicate market growth.

Areas ripe for innovation and research include the development of portable detection devices, automation of testing processes, and integration with bioinformatics tools for enhanced data analysis. Collaborations between biotech firms and academic institutions could drive advancements further. The market is characterized by rapid technological developments and increasing competition, necessitating continuous innovation and strategic partnerships to maintain a competitive edge. Leveraging breakthroughs in artificial intelligence for predictive analytics in genome editing outcomes represents a promising avenue for gaining insights and achieving business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mutation Detection Kits In Genome Editing Market

The Mutation Detection Kits In Genome Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of genetic disorders and cancer
  • Rising investments in genetic research and personalized medicine
• Market Restraints
  • High costs and complex regulations associated with genome editing technologies
• Market Opportunities
  • Innovations in sequencing technologies and bioinformatics
  • Increasing collaboration between biotech firms and research institutions
• Market Challenges
  • Technical limitations and accuracy concerns associated with the mutation detection kits

Porter's Five Forces: A Strategic Tool for Navigating the Mutation Detection Kits In Genome Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mutation Detection Kits In Genome Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mutation Detection Kits In Genome Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mutation Detection Kits In Genome Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mutation Detection Kits In Genome Editing Market

A detailed market share analysis in the Mutation Detection Kits In Genome Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mutation Detection Kits In Genome Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mutation Detection Kits In Genome Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mutation Detection Kits In Genome Editing Market

A strategic analysis of the Mutation Detection Kits In Genome Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mutation Detection Kits In Genome Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Applied Biological Materials, Inc., Bio-Rad Laboratories, BIOKE, B.V. by Cell Signaling Technology, Inc., Bioneer Corporation, Biovision Inc. by Abcam Limited, GenScript Biotech Corporation, Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Launch Diagnostics Limited by Avacta Group Plc, LGC Biosearch Technologies, Lonza Group AG, Medaysis Company, Merck KGaA, Mylab Discovery Solutions Pvt. Ltd., New England Biolabs, New England Biolabs, Inc., Origene Technologies, Inc., Promega Corporation, Qiagen N.V., Synthego Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd., and TRUPCR by Kilpest India Limited.

Market Segmentation & Coverage

This research report categorizes the Mutation Detection Kits In Genome Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Genome, market is studied across CRISPR/Cas9, Meganucleases, TALENs/MegaTALs, and ZFN.
• Based on End-Use, market is studied across Academic Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of genetic disorders and cancer
    • 5.1.1.2. Rising investments in genetic research and personalized medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High costs and complex regulations associated with genome editing technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in sequencing technologies and bioinformatics
    • 5.1.3.2. Increasing collaboration between biotech firms and research institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations and accuracy concerns associated with the mutation detection kits
• 5.2. Market Segmentation Analysis
  • 5.2.1. Genome: Expanding commercialization of CRISPR/Cas9 with broad applications and ongoing therapeutic developments
  • 5.2.2. End-Use: Increasing demand by academic research institutes for development of new gene editing techniques
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Mutation Detection Kits In Genome Editing Market, by Genome

• 6.1. Introduction
• 6.2. CRISPR/Cas9
• 6.3. Meganucleases
• 6.4. TALENs/MegaTALs
• 6.5. ZFN

7. Mutation Detection Kits In Genome Editing Market, by End-Use

• 7.1. Introduction
• 7.2. Academic Research Institutes
• 7.3. Biotechnology & Pharmaceutical Companies
• 7.4. Contract Research Organizations

8. Americas Mutation Detection Kits In Genome Editing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Mutation Detection Kits In Genome Editing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Mutation Detection Kits In Genome Editing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Inocras and Watchmaker Genomics announce strategic collaboration to develop advanced genome editing solutions
  • 11.3.2. FDA approves Prime Medicine's IND for first prime editing therapy
  • 11.3.3. Regeneron and Mammoth Biosciences launch collaboration for in vivo CRISPR gene editing
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Amoy Diagnostics Co., Ltd.
• 3. Applied Biological Materials, Inc.
• 4. Bio-Rad Laboratories
• 5. BIOKE, B.V. by Cell Signaling Technology, Inc.
• 6. Bioneer Corporation
• 7. Biovision Inc. by Abcam Limited
• 8. GenScript Biotech Corporation
• 9. Illumina, Inc.
• 10. Integrated DNA Technologies, Inc. by Danaher Corporation
• 11. Launch Diagnostics Limited by Avacta Group Plc
• 12. LGC Biosearch Technologies
• 13. Lonza Group AG
• 14. Medaysis Company
• 15. Merck KGaA
• 16. Mylab Discovery Solutions Pvt. Ltd.
• 17. New England Biolabs
• 18. New England Biolabs, Inc.
• 19. Origene Technologies, Inc.
• 20. Promega Corporation
• 21. Qiagen N.V.
• 22. Synthego Corporation
• 23. Takara Bio Inc.
• 24. Thermo Fisher Scientific Inc.
• 25. TransGen Biotech Co., Ltd.
• 26. TRUPCR by Kilpest India Limited